BPGAM
BMY.RT

BTG Pactual Global Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

BTG Pactual Global Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-124,789
Closed -$86K – 117
2020
Q4 		$86K Buy
124,789
+63,200
+103% +$135K 0.01% 89
2020
Q3 		$139K Sell
61,589
-6,353
-9% -$18.1K 0.02% 121
2020
Q2 		$243K Buy
67,942
+10,000
+17% +$36.1K 0.03% 102
2020
Q1 		$220K Sell
57,942
-60,000
-51% -$198K 0.03% 99
2019
Q4 		$355K Buy
+117,942
New +$307K 0.06% 85

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

BTG Pactual Global Asset Management's BMY.RT Position: Q1 2021 in Review

BTG Pactual Global Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 124,789 shares — an estimated $86K sold.

BTG Pactual Global Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $355K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • BTG Pactual Global Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 124,789 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $86K.
  • BTG Pactual Global Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • BTG Pactual Global Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $355K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on BTG Pactual Global Asset Management's 13F filing for Q1 2021, filed 14 May 2021.